Renaissance of Medicine
ABOUT US
Renaissance of Medicine
2025
05 - Selected for University-Based Startup Support
Program
04 - Selected for KDCA Program for Pandemic
mRNA Vaccine Development
2024
12 - Secured Series A Funding from Eyegene,
and others
10 - Selected for the Deep Tech TIPS Program
06 - Selected for Global Top Strategic Research
Program
2023
12 - Selected in Coalition for Epidemic Preparedness Innovations (CEPI) program with Chungbuk National University and Microuni
10 - Selected in Korea Drug Development Fund (KDDF) program for the MDC-101 project
04 - Selected in the Local Specialized
Business program of Ministry of SMEs
and Startups for the MDC-002 project
2022
07 - Selected in TIPS program (MDC-101)
05 - Investment attraction from Chungbuk Center for Creative Economy and Innovation
- Investment attraction from Myriad
Life Sciences and MediciBIO
03 - Certified as a Technology Innovation- Oriented Small and Medium Enterprise
01 - R&D center is designated as a Biosafety Level 2 facility
2021
12 - Certified as a corporate R&D center
11 - MediciBIO was founded
Company History
2025 | 05 |
|
04 |
| |
2024 | 12 |
|
10 |
| |
06 |
| |
2023 | 12 |
|
10 |
| |
04 |
| |
2022 | 07 |
|
05 |
| |
03 |
| |
01 |
| |
| | ||
2021 | 12 |
|
11 |
| |
Addressㅣ A-2207, 184, Jungbu-daero, Giheung-gu, Yongin-si,
Gyeonggi-do, 17095 Republic of Korea
Telㅣ +82-31-895-6710 Faxㅣ +82-70-8676-6706
Copyright © MediciBIO Co.,LTD. All rights reserved.
Headquarter A-2207, 184, Jungbu-daero, Giheung-gu, Yongin-si, Gyeonggi-do, 17095 Republic of Korea
Branch Office A-13, 3rd Floor, 194-25, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 28160 Republic of Korea
Tel ㅣ +82-31-895-6710 Fax ㅣ +82-70-8676-6706 Email ㅣ biz@medicibio.com
Copyright © MediciBIO Co.,LTD. All rights reserved.
